| Income Statement | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-06-30 |
|---|---|---|---|---|
| Decrease of contingent liability | 0 | - | - | - |
| Loss before provision for income taxes | -895,272 | -480,757 | 15,095 | 459,737 |
| Net loss (income) | -895,272 | -480,757 | 15,095 | 459,737 |
| Preferred dividends | 333,500 | 1,000,500 | 1,000,501 | 1,000,500 |
| Net loss attributable to cbdmd, inc. common shareholders | -1,228,772 | -1,481,257 | -985,406 | -540,763 |
| Diluted eps | - | - | - | -0.15 |
| Basic and diluted earnings per share (in dollars per share) | -0.21 | -1.9 | -0.22 | -0.15 |
| Weighted average number of shares basic and diluted (in shares) | 5,783,354 | 778,410 | 4,552,067 | 3,592,969 |
cbdMD, Inc. (YCBD)
cbdMD, Inc. (YCBD)